Analysis and Commentary 12/5/20 Analysis and Commentary 12/5/20 CDRH Update and Future Priorities Read More Advocacy at a Glance 11/20/20 Advocacy at a Glance 11/20/20 What Happened in 2020? Insights from DC's Top Election Handicapper Read More Advocacy at a Glance 11/13/20 Advocacy at a Glance 11/13/20 Progress on Appropriations; How Much Progress is Unclear Read More Advocacy at a Glance 11/8/20 Advocacy at a Glance 11/8/20 Alliance Webinar with CDRH Director Dr. Jeffrey Shuren Announced Read More Advocacy at a Glance 10/31/20 Advocacy at a Glance 10/31/20 Pandemic-Related Aid and Delayed Appropriations: to Be Resolved Together in Lame Duck? Read More Analysis and Commentary 2/7/20 Analysis and Commentary 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More Advocacy at a Glance 11/30/18 Advocacy at a Glance 11/30/18 A Full Year Continuing Resolution: The Biggest Threat to FDA’s FY19 Funding Read More Advocacy at a Glance 9/9/16 Advocacy at a Glance 9/9/16 CDRH Director Shuren’s Presentation Well Received. Read More Advocacy at a Glance 8/28/16 Advocacy at a Glance 8/28/16 Congress Returns Soon; Unclear How Long It Will Stay Read More
Analysis and Commentary 12/5/20 Analysis and Commentary 12/5/20 CDRH Update and Future Priorities Read More
Advocacy at a Glance 11/20/20 Advocacy at a Glance 11/20/20 What Happened in 2020? Insights from DC's Top Election Handicapper Read More
Advocacy at a Glance 11/13/20 Advocacy at a Glance 11/13/20 Progress on Appropriations; How Much Progress is Unclear Read More
Advocacy at a Glance 11/8/20 Advocacy at a Glance 11/8/20 Alliance Webinar with CDRH Director Dr. Jeffrey Shuren Announced Read More
Advocacy at a Glance 10/31/20 Advocacy at a Glance 10/31/20 Pandemic-Related Aid and Delayed Appropriations: to Be Resolved Together in Lame Duck? Read More
Analysis and Commentary 2/7/20 Analysis and Commentary 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More
Advocacy at a Glance 11/30/18 Advocacy at a Glance 11/30/18 A Full Year Continuing Resolution: The Biggest Threat to FDA’s FY19 Funding Read More
Advocacy at a Glance 9/9/16 Advocacy at a Glance 9/9/16 CDRH Director Shuren’s Presentation Well Received. Read More
Advocacy at a Glance 8/28/16 Advocacy at a Glance 8/28/16 Congress Returns Soon; Unclear How Long It Will Stay Read More
